Fundz

Elicio Therapeutics, Inc. reported raising $975,000 in an initial SEC Form D filing, from an offering of $50 Million

PRIVATEMay 27, 2022$975K of $50M raised

Amount Raised

$975,000

$975,000 sold, per SEC Form D (first sale May 27, 2022)

Round Type

Series B

BostonBiotechnology

Quick answer

Elicio Therapeutics raised $975,000 in a Series B round, dated May 27, 2022. Elicio Therapeutics is based in Boston, Massachusetts, United States.

How much did Elicio Therapeutics raise?
Elicio Therapeutics raised $975,000 in a Series B round on May 27, 2022.
What does Elicio Therapeutics do?
Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer.
Where is Elicio Therapeutics based and how big is it?
Elicio Therapeutics is based in Boston, Massachusetts, United States. Fundz records about 42 employees.
Who are the decision-makers at Elicio Therapeutics?
Fundz holds 1 contact at Elicio Therapeutics, including the Chief Scientific Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Elicio Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • ProtoKinetix raised $80K (Seed) on July 11, 2022.
  • CytoRecovery, Inc. raised $2.1M (Seed) on July 11, 2022.
  • Secure AI Labs raised $7.9M on July 11, 2022.
  • ImmunityBio raised $11M on July 9, 2022.
  • Ensysce Biosciences raised $4.2M (Seed) on July 8, 2022.
  • Novasenta Inc. raised $10M on July 8, 2022.

Who to call at Elicio Therapeutics, and when

A new round usually means Elicio Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Elicio Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Elicio Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Elicio Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Elicio Therapeutics

Location

ONE KENDALL SQUARE

Boston, Massachusetts, United States

About

Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer. By combining expertise in immunology and immunotherapy, Elicio is engineering investigational Amphiphile (“AMP”) immunotherapies intended to precisely target and fully engage the lymph nodes, the site in our bodies where the immune response is orchestrated. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Elicio Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsPeter D., Chief Scientific OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Elicio Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Elicio Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.